Keith Siau (@drkeithsiau) 's Twitter Profile
Keith Siau

@drkeithsiau

GI doctor with interests in endoscopy, gut health, liver & medicine. 💜 #GITwitter #LiverTwitter #MedEd. Occasional silliness. Siau rhymes with meow 😺

ID: 563168113

linkhttps://bit.ly/2lnI7Q2 calendar_today25-04-2012 20:20:13

42,42K Tweet

178,178K Followers

4,4K Following

Keith Siau (@drkeithsiau) 's Twitter Profile Photo
Keith Siau
@drkeithsiau

13 days ago

Head-to-head RCT of Risankizumab vs Ustekinumab in moderate-severe Crohn’s disease. Endoscopic remission at week 48 was superior with Risankizumab (32% vs 16%). nejm.org/doi/full/10.10…

Head-to-head RCT of Risankizumab vs Ustekinumab in moderate-severe Crohn’s disease. Endoscopic remission at week 48 was superior with Risankizumab (32% vs 16%). nejm.org/doi/full/10.10…